aod9604 human clinical trials weight loss results The effects of 14 day infusion of saline (control), (250 AOD-9604 Peptide | USA Made
Description
Monitoring Protocol: Although the trials showed no concerning laboratory changes, prudent clinical practice suggests baseline and periodic monitoring of metabolic parameters, complete blood counts, liver function, and kidney function
AOD 9604 is not FDA-approved for fat loss or any other indication
investigational only
The fasted cardio stack protocol most commonly described in research communities: Wake up fasted (812 hours post last meal)
Clinical research provides guidance on safe, effective treatment durations
